Results 221 to 230 of about 55,181 (252)
Some of the next articles are maybe not open access.
2016
Upon completion of the chapter, the reader will be able to: 1. Differentiate epidemiologic differences and host risk factors for acquisition of primary and opportunistic invasive fungal diseases. 2. Recommend appropriate empiric or targeted antifungal therapy for the treatment of invasive fungal disease. 3.
Lewis RE, Rogers PD
openaire +3 more sources
Upon completion of the chapter, the reader will be able to: 1. Differentiate epidemiologic differences and host risk factors for acquisition of primary and opportunistic invasive fungal diseases. 2. Recommend appropriate empiric or targeted antifungal therapy for the treatment of invasive fungal disease. 3.
Lewis RE, Rogers PD
openaire +3 more sources
Archives of Internal Medicine, 1983
• Serologic tests are useful in providing a presumptive diagnosis of invasive fungal infection, allowing early institution of specific therapy. The judicious use of these serologic tests for circulating antibodies or antigens also may aid in analyzing response to treatment and in assessing prognosis.
openaire +1 more source
• Serologic tests are useful in providing a presumptive diagnosis of invasive fungal infection, allowing early institution of specific therapy. The judicious use of these serologic tests for circulating antibodies or antigens also may aid in analyzing response to treatment and in assessing prognosis.
openaire +1 more source
Tailored Treatment of Invasive Fungal Infections
Future Microbiology, 2008The need to tailor antifungal treatment to local epidemiology and individual patient risk was a key theme of the 3rd Trends in Medical Mycology (TIMM-3) congress in Turin, Italy, 28–31 October 2007. Organized jointly by the European Confederation of Medical Mycology (ECMM) and the Infectious Diseases Group of the European Organisation for Research and ...
Johan, Maertens, Jenny, Bryan
openaire +2 more sources
Agents for treatment of invasive fungal infections
Otolaryngologic Clinics of North America, 2000The incidence of fungal infections continues to rise as the population of immunocompromised individuals increases. Despite the enlarging numbers of infections, there are only a few antifungal agents for treatment of deep-seated, invasive infections. These agents include amphotericin B, flucytosine, terbinafine, and several azoles.
B, Luna, R H, Drew, J R, Perfect
openaire +2 more sources
Invasive Fungal Infections in the Era of Biologics
Clinics in Chest Medicine, 2009With the advent and widespread use of immunomodulating biologic agents, emerging invasive fungal infections are reported increasingly. To date there is no reliable method to screen patients before starting anti-tumor necrosis factor (TNF) therapy to predict their risk for acquiring fungal infections, partly because most of these infections are de novo ...
Tamra M, Arnold +2 more
openaire +2 more sources
Voriconazole in the treatment of invasive fungal infections
Intensive and Critical Care Nursing, 2005Fungal infections in immunocompromised patients in the Intensive Care Unit (ICU) are a major cause of mortality and morbidity and can lead to extended stays on the ICU. New antifungal drugs have been developed to increase treatment options to improve the clinical outcome.
Simon, Keady, Meera, Thacker
openaire +2 more sources
Invasive fungal infections in the pediatric population
Expert Review of Anti-infective Therapy, 2011Expert Rev. Anti Infect. Ther. 9(3), 275-278 (2011) Invasive fungal infections (IFIs) are increasing in incidence and constitute an important cause of morbidity and mortality in immunocompromised pediatric patient populations, including, but not limited to, preterm neonates, children and adolescents with hematologic malignancies, and those undergoing ...
Thomas, Lehrnbecher, Andreas H, Groll
openaire +2 more sources
Treatment Options for Invasive Fungal Infections
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2006Clinicians face an increasing occurrence of invasive fungal infections. These are due not only to traditional yeast and mould species but also to rare pathogens that can be difficult to treat. The introduction of new agents has expanded the options for treating common and rare mycotic infections with antifungal efficacy at least equal, and safety far ...
openaire +2 more sources
New approaches to invasive fungal infections
Current Opinion in Hematology, 2003Invasive fungal infections are typically difficult to prevent, diagnose, and treat; consequently, fungal infection-related mortality has become high, particularly among patients with prolonged neutropenia and severe graft-versus-host disease. However, much recent progress has been made in understanding the immune response to fungi and the epidemiology ...
openaire +2 more sources
Invasive Fungal Infections of the Orbit
International Ophthalmology Clinics, 2007James, Kirszrot, Peter A D, Rubin
openaire +2 more sources